NIH-funded research R21 grant

Investigating how anandamide affects blood pressure control

Official title: Anandamide in blood pressure control

Funded at University of Colorado Denver · NIH-11078318 · Data updated 2026-11-12

This study is looking at how a natural substance in your body called anandamide affects blood pressure, especially for people with high blood pressure, to find new ways to help manage it better and keep your heart healthy.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startMay 1, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$94,500
NIH project number5R21HL169709-02
Project IDNIH-11078318 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who are experiencing hypertension or related cardiovascular issues.

Less likely to help

Patients with stable blood pressure and no history of hypertension or cardiovascular disease may not benefit from this research.

What this research studies

This research explores the role of anandamide, a naturally occurring compound in the body, in regulating blood pressure, particularly in individuals with hypertension. The study aims to understand how the endocannabinoid system, which includes anandamide, interacts with the body's mechanisms for controlling blood pressure and how this may lead to adverse effects in patients undergoing treatment for hypertension. By examining the relationship between anandamide levels and blood pressure responses, the research seeks to identify potential new therapeutic strategies for managing hypertension and reducing the risk of cardiovascular events.

Why it matters

Potential benefit: If successful, this research could lead to improved blood pressure management strategies that minimize adverse effects for patients with hypertension.

How similar studies have gone: Previous studies have shown promising results regarding the role of the endocannabinoid system in blood pressure regulation, indicating that this approach may yield valuable insights.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Klawitter, Jelena — University of Colorado Denver
  • Study coordinator: Klawitter, Jelena

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.